Cement Enterprises in Southwest Yunnan to Deeply Promote Staggering Production
Release time:
2021-05-21
5# April 18 , the peak shifting production promotion meeting of the cement industry in southwest Yunnan was held in Yunnan Jianfeng Cement Company. Yunnan Cement Association, Yunnan Cement Association Southwest Yunnan Branch and the heads of cement enterprises in the region gathered together to reach a consensus on the further promotion of peak shifting production. During the "13th Five-Year Plan" period, the cement industry's staggered peak production has been normalized nationwide, effectively alleviating the contradiction between supply and demand caused by overcapacity, reducing air pollution emissions, and achieving obvious economic, environmental and social benefits. This meeting reported the implementation inspection of off-peak production by cement clinker production enterprises in southwest Yunnan from November 1 to November
4, and some enterprise representatives shared their experience in off-peak production. Fang Xuhua, vice president of Yunnan Cement Association and chairman of Southwest Yunnan Branch, analyzed the problems and severe situation in combination with the cement market situation in Southwest Yunnan since this year. At this stage, due to the changes in the relationship between supply and demand, the release of new production capacity, the overall production capacity is not ideal and other factors, the market fluctuates, and disorderly competition appears in some areas, which is extremely unfavorable to maintaining the stability of the regional market. Fang Xuhua pointed out that Yunnan is the southwest gateway of "Belt and Road Initiative" and a province with large sources of tourism and biological resources, and staggered peak production, emission reduction and efficiency increase are of great significance to protecting the ecological environment and promoting the stable and coordinated development of the local economy. All enterprises should take practical actions to support the social responsibility of energy conservation and emission reduction in peak shifting production, and jointly maintain the healthy development of the industry.
After full deliberation and discussion, the participating member units reached a consensus on the energy conservation, emission reduction, green production and other related work of enterprises in the region in the next period, and formed specific work arrangements. Representatives of the participating enterprises made statements one after another, saying that they would resolutely implement the spirit of the meeting, take the off-peak production of cement as the key work of their respective enterprises in the next step, and earnestly implement the new requirements of high-quality development of the cement industry. (hu chuanli)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31